Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Israeli Stocks: Teva, Ampal, Elad, Marathon, Gazit-Globe, Tower

Israel’s TA-25 Index declined from an almost three-month high, slipping less than 0.1 percent to 1,136.43, at the 4:30 p.m. close in Tel Aviv.

The following stocks rose or fell today. Symbols are in parentheses.

Ampal-American Israel Corp. (AMPL IT), the owner of a stake in a company that exports gas from Egypt to Israel, advanced for the fifth time in six days, gaining 1.3 percent to 1.625 shekels. Ampal said the gas supply from Egypt to Israel has been restored partially after being halted following explosions on the Sinai-pipeline network.

Elad Canada Inc. (ELCN IT) gained to the highest level since Aug. 4, advancing 3.1 percent to 10.62 shekels. The real estate company said it plans to pay a dividend of 75 million shekels ($20 million).

Gazit-Globe Ltd. (GLOB IT) rose to the highest since Dec. 26, adding 1.1 percent to 37.38 shekels. The real-estate company agreed to sell about 134.7 million shekels of bonds and 1.3 million options to institutional investors.

Separately, the company said it bought 1 million shares of Atrium European Real Estate Ltd. (ATRS AV) for 3.58 euros each, increasing its stake in the manager of retail-real estate to 32.46 percent.

Marathon Investments Ltd. (MARA IT) soared 46 percent, the most since at least February 1996 when Bloomberg started tracking the stock, to 1.078 shekels. The venture capital fund said it is in talks to sell a unit for 210 million shekels.

Strauss Group Ltd. (STRS IT) climbed to the highest since Jan. 2, advancing 0.8 percent to 46.97 shekels. The food, snack and coffee maker said its coffee unit signed a five-year agreement with a German manufacturer to produce coffee.

Teva Pharmaceutical Industries Ltd. (TEVA IT), the generic drugmaker whose bestselling medicine is Copaxone, an injectable treatment for multiple sclerosis, advanced to the highest since May 31, increasing 0.9 percent to 173.50 shekels. U.S. and European regulators said they were reviewing Novartis AG ’s multiple sclerosis pill Gilenya after reports of 11 deaths.

Tower Semiconductor Ltd. (TSEM IT) rose 4.7 percent to 2.689 shekels, or the equivalent of 71 cents, the highest since Nov. 16. The U.S.-traded shares of the maker of customized chips rose 5.1 percent to 72 cents on Jan. 20.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.